Prof. karen L. wooley

Inventor and Chief Technology Officer

Karen L. Wooley is the W. T. Doherty-Welch Chair in Chemistry, a University Distinguished Professor and a Presidential Impact Fellow at Texas A&M University, where she holds appointments in the departments of Chemistry, Chemical Engineering and Materials Science & Engineering.She also serves as director of the Laboratory for Synthetic-Biologic Interactions.Karen has served on the technical advisory boards and served in consulting capacities for several companies, from Fortune 500 companies to start-ups, and law firms.Her expertise crosses the disciplines of synthetic organic and polymer chemistries, with an emphasis on the development of synthetic methodologies, fundamental study of physicochemical and mechanical properties, and investigation of the functional performance of her materials in the diagnosis and treatment of disease, as non-toxic anti-biofouling or anti-icing coatings, as materials for microelectronics device applications, and as environmental remediation systems. Karen currently serves as an associate editor for the Journal of the American Chemical Society, among many other advisory roles within the broader scientific community.

Clive has broad international experience as a CEO across a variety of industrial sectors and is now a business angel, adviser and non-executive director to small businesses. His experience encompasses senior roles in the packaging, plastics, engineering and chemical industries. He has been based mainly in the UK, with spells in Singapore and Germany, and with responsibility for businesses based in North America, Europe and Asia. Latterly he was divisional chairman of Laporte Fine Chemicals until its acquisition by Degussa, when he became vice president of Degussa Fine Chemicals. In October 2008 Clive was appointed the UK’s nominated expert on climate change to the UNFCCC (United Nations Framework Convention on climate change). He is a graduate of St. Andrews University, where he obtained an honours B.Sc. in Chemistry and a PhD for research into polymer behaviour.

DR. clive rankin

Chairman

Matthew Stone

Managing Director

Matthew is a specialist in technology transfer from laboratory to industry, and provides commercialisation consultancy to some of the world’s leading research centres, as well as some of the most innovative private businesses. From a corporate finance background, he has specialised in biomass processing, energy, and clean technology for over 12 years, and has successfully launched numerous projects from concept to commercial realisation. Today Matthew is the founder and major shareholder of several successful companies, including Renovare Fuels, US Cleantech and Nextgen Nano. He maintains extensive contacts both in industry and research, and provides unrivalled operational and strategic insight. Matthew’s past and present clients include government agencies in Europe, US, Africa and Asia, as well as some of the largest corporate entities on the UK, French, US, Singapore, Malaysian, and Indian exchanges. His current areas of activity include bio-chemistry, waste to energy and nanotechnology, and he has gained an international reputation for developing technology start-ups into highly valued commercial entities.

Steve is a highly experienced practitioner of industrial biocatalysis with a broad knowledge of enzyme and chemical technologies in the pharmaceutical, fine chemical and biofuels sectors. With 25+ years in these industries, his career has ranged from start-ups to global chemical companies, including proven leadership of a multidisciplinary biocatalysis department. In these roles many enzyme processes have been developed for the production of drug intermediates, involving molecular biology, fermentation science and chemical process development. Steve has a passion for science, innovation and its role in developing new businesses, generating new opportunities by creatively combining different disciplines in new ways. For example, he has developed ultra-green routes to natural ingredients by processes using ultrasonics and enzyme chemistry.

Steve is a biochemistry graduate of Imperial College, London, where he received a 1st class BSc and PhD and was awarded the Governor’s Prize for Biochemistry. Over the years he has published many papers across a range of disciplines, from process chemistry to drug discovery.

DR. Steve Taylor

Technology Development Director

Dr Ashlee A. Jahnke

Head of Research and Development

After completing her B.Sc. in Chemistry from Texas A&M University in 2007, Ashlee spent time as a research assistant at Lynntech, where she worked on a diverse portfolio of projects with applications ranging from biofuel production to photodynamic therapy agents. After over a year in industry, Ashlee joined the PhD. program in the Department of Chemistry at The University of Toronto in 2009, where she was a Colin Hahnemann Bayley Fellow. After receiving her PhD. in Polymers and Materials Chemistry in 2014, Ashlee returned to Texas A&M University as a postdoctoral research associate. In 2016, Ashlee served as an entrepreneurial lead in the NSF Innovation Corps programme, and has since transitioned to research in natural-product based degradable polymer systems with a focus on their scale-up and commercialisation.